Subscribe to our Telegram channel to get a daily dose of business and lifestyle news from NHA – News Hub Asia!
- China has approved a new COVID-19 vaccine for emergency use, one that was developed by the head of its Center for Disease Control and Prevention (CDC), adding to its arsenal.
- Gao Fu, the head of China’s CDC, led the development of a protein subunit vaccine that was approved by regulators last week for emergency use, the Chinese Academy of Sciences’ Institute of Microbiology said in a statement on Monday.
- It is the fourth such vaccine to be given emergency use approval. China has approved four vaccines developed by three Chinese companies for general use.
- The vaccine was developed jointly by Anhui Zhifei Longcom Biopharmaceutical and the Chinese Academy of Sciences. The team finished phase one and phase two clinical trials in October of last year and is currently conducting the last phase of trials in Uzbekistan, Pakistan and Indonesia, according to the statement.
- The vaccine was approved for use in Uzbekistan on Mar 1.
What is your plan for crisis control? Need help managing your organization crisis? Each crisis is different, if you have a crisis contact us immediately at https://www.crisismanagementcentre.com/contact-us/
We are ready to manage your crisis.